Robert M. Davis

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Rahway, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/David S. Maltz, attorney-in-fact for Robert M. Davis
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert M. Davis

Form 4 holding Chairman, CEO & President, Director

Merck & Co., Inc.

Security class
Common Stock
Shares / value
450,351
Estimated value
$54,172,692
Report date
05 May 2026
Price
$120.29
Ownership
Direct
Form 4 holding Chairman, CEO & President, Director

Merck & Co., Inc.

Security class
Stock Option (Right to Buy)
Shares / value
139,697
Estimated value
Report date
05 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman, CEO & President, Director

Merck & Co., Inc.

Security class
Restricted Stock Unit
Shares / value
47,724
Estimated value
Report date
05 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert M. Davis

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .